GoodRx Holdings, Inc. (GDRX) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

GoodRx Holdings, Inc. (GDRX) Healthcare & Pipeline Overview

GoodRx Holdings, Inc. is a leading healthcare technology firm specializing in prescription drug price comparison, empowering consumers to save money through negotiated discounts and a user-friendly platform, while addressing the rising costs of healthcare in the U.S.

What Is the Investment Thesis for GDRX?

With a market capitalization of $1.17B and a P/E ratio of 63.69, the company operates in a high-margin environment, boasting a gross margin of 89.3%. The ongoing shift towards digital healthcare solutions and price transparency positions GoodRx favorably within the industry. The increasing demand for cost-effective healthcare options, particularly in the wake of rising prescription drug prices, is expected to drive user engagement and platform adoption. Furthermore, the company's expansion into telehealth services and partnerships with pharmaceutical manufacturers could enhance revenue streams and market presence. However, the company faces ongoing risks, including regulatory challenges and competition from other healthcare technology firms. Investors should closely monitor these dynamics as GoodRx continues to evolve.

Based on FMP financials and quantitative analysis

GDRX Key Highlights

Market Cap of $1.17B reflects strong positioning in healthcare technology.

• P/E ratio of 63.69 indicates investor confidence in future growth.
• Gross margin of 89.3% highlights operational efficiency and profitability potential.
• Profit margin of 3.7% suggests room for improvement in cost management.
• Beta of 1.47 indicates higher volatility compared to the market, reflecting investor sentiment.

Who Are GDRX's Competitors?

GDRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are GDRX's Key Strengths?

Strong market presence in prescription drug price comparison.

• High gross margin indicating operational efficiency.
• Diverse service offerings including telehealth and subscriptions.

What Are GDRX's Weaknesses?

Relatively low profit margin compared to industry standards.

• Dependence on advertising revenue which may fluctuate.
• Limited international presence.

What Could Drive GDRX Stock Higher?

Expansion of telehealth services to capture a growing market.

• Increasing user engagement driven by rising prescription drug prices.
• Strategic partnerships with pharmaceutical manufacturers to enhance service offerings.

What Are the Key Risks for GDRX?

Financial-distress signal — its Altman Z-Score of 0.25 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
• Rich valuation — a P/E of 63.69 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.
• Regulatory changes that could impact pricing strategies.
• Competition from established healthcare firms and new entrants.
• Fluctuations in advertising revenue affecting overall profitability.

What Are the Growth Opportunities for GDRX?

• Growth opportunity 1: GoodRx's expansion into telehealth services represents a significant growth driver. The telehealth market is projected to reach $459.8 billion by 2030, driven by increased consumer adoption and demand for convenient healthcare solutions. GoodRx's established user base and brand trust can facilitate rapid growth in this segment, enhancing overall revenue.
• Growth opportunity 2: The increasing focus on prescription drug price transparency presents an opportunity for GoodRx to capture a larger market share. As consumers become more aware of their medication costs, the demand for price comparison tools is expected to grow. This trend could lead to increased user engagement and higher transaction volumes on the platform.
• Growth opportunity 3: Partnerships with pharmaceutical manufacturers can enhance GoodRx's service offerings and create new revenue streams. By collaborating with drug manufacturers, GoodRx can provide exclusive discounts and access to promotional pricing, further attracting consumers to its platform and increasing its competitive advantage.
• Growth opportunity 4: Geographic expansion into underserved markets can drive user growth. By targeting areas with limited access to affordable medications, GoodRx can establish itself as a key player in these regions, potentially increasing its user base and transaction volume significantly.
• Growth opportunity 5: The rise of personalized medicine and targeted therapies can create demand for GoodRx's services as consumers seek cost-effective options for specialized medications. By positioning itself as a trusted resource for pricing information on these therapies, GoodRx can tap into a growing segment of the healthcare market.

What Threats Does GDRX Face?

• Regulatory challenges impacting pricing models.
• Intense competition from other healthcare technology firms.
• Potential changes in consumer behavior affecting platform usage.

What Are GDRX's Competitive Advantages?

• Established brand recognition and trust among consumers.
• User-friendly platform that simplifies price comparison.
• Strong partnerships with pharmacies and pharmaceutical companies.
• Proprietary data analytics capabilities for better service delivery.

What Does GDRX Do?

GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California. The company was founded with the mission of making prescription medications more affordable and accessible to consumers in the United States. Through its innovative price comparison platform, GoodRx enables users to compare prices for prescription drugs at local pharmacies, providing them with curated, geographically relevant pricing information. The platform allows consumers to access negotiated prices through GoodRx codes, which can be used to save money on their prescriptions. In addition to its core offerings, GoodRx has expanded its services to include telehealth solutions, subscription services, and partnerships with pharmaceutical manufacturers, enhancing its value proposition in the healthcare market. The company serves a diverse clientele, including pharmacy benefit managers who manage formularies and prescription transactions, thereby establishing pricing between consumers and pharmacies. GoodRx has positioned itself as a critical player in the healthcare information services industry, leveraging technology to disrupt traditional pharmacy practices and improve consumer access to affordable medications. As of now, GoodRx employs approximately 738 individuals, reflecting its growth and commitment to delivering innovative healthcare solutions.

What Products and Services Does GDRX Offer?

• Operate a price comparison platform for prescription drugs in the U.S.
• Provide consumers with tools to compare medication prices at local pharmacies.
• Offer negotiated prices through GoodRx codes for savings on prescriptions.
• Deliver telehealth services for convenient access to healthcare providers.
• Facilitate partnerships with pharmaceutical manufacturers for exclusive discounts.
• Serve pharmacy benefit managers to manage formularies and pricing.

How Does GDRX Make Money?

• Generate revenue through advertising partnerships with pharmacies and pharmaceutical companies.
• Earn fees from telehealth services provided to consumers.
• Offer subscription services that provide additional benefits to users.
• Leverage data analytics to enhance service offerings and improve user experience.

What Industry Does GDRX Operate In?

The healthcare information services industry is experiencing significant growth, driven by the increasing demand for transparency in prescription drug pricing and the rising costs of healthcare. The market is projected to expand as consumers seek cost-saving solutions and as technology continues to play a crucial role in healthcare delivery. GoodRx Holdings, Inc. is well-positioned within this landscape, leveraging its price comparison platform to meet the needs of cost-conscious consumers. The competitive landscape includes various players offering similar services, but GoodRx's established brand recognition and user-friendly platform provide a competitive edge.

Who Are GDRX's Key Customers?

• Individual consumers seeking affordable prescription medications.
• Pharmacy benefit managers looking to manage prescription pricing.
• Pharmacies aiming to attract more customers through competitive pricing.
• Pharmaceutical manufacturers interested in promoting their products.

GoodRx Holdings, Inc. Financial Trajectory

GoodRx Holdings, Inc. (GDRX) reported $200.4M in revenue for Q2 FY2026, reflecting 3.3% growth compared to the prior quarter. The company recorded net income of $8.5M, with diluted EPS of $0.02. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, GDRX averaged $0.01 in diluted EPS.

Company Profile

GoodRx Holdings, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Santa Monica, US. The company is led by CEO Wendy Barnes. GDRX has traded publicly since 2020.

How GoodRx Holdings, Inc. Is Valued

GoodRx Holdings, Inc. carries a market capitalization of $1.17B, placing it in the small-cap category. Analyst price targets span from $3.75 to $5.00, with a consensus of $4.19. At the current price of $3.38, that implies approximately 24% upside potential. Relative to its peer group, GDRX's quantitative score of 47/100 is below the peer average of 64/100.

Return on equity for GoodRx Holdings, Inc. stands at 3.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.0%, showing how much profit it generates from its asset base. GDRX trades at a trailing price-to-earnings ratio of 63.69, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 9.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.47 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.0%, the inverse of the P/E and a quick read on earnings relative to price.

GoodRx Holdings, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.25 places it in the distress zone, a signal of elevated financial risk.

GoodRx Holdings, Inc. has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 5.2% below estimates on average.

Over the past six months, GoodRx Holdings, Inc. insiders filed 87 SEC Form 4 transactions — 55 sales and 32 purchases. On net that is roughly 6.4M shares disposed (about $8.7M), a signal worth weighing alongside the fundamentals.

GDRX Financials

GDRX Latest News

GDRX Analyst Consensus

GDRX MoonshotScore

GoodRx Holdings, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources